THYROCARE

Thyrocare Technologies Share Price

 

 

Start SIP in THYROCARE

Start SIP

Performance

  • Low
  • ₹447
  • High
  • ₹455
  • 52 Week Low
  • ₹219
  • 52 Week High
  • ₹537
  • Open Price₹455
  • Previous Close₹457
  • Volume214,992

Investment Returns

  • Over 1 Month -7.47%
  • Over 3 Month + 12.63%
  • Over 6 Month + 42.03%
  • Over 1 Year + 46.89%

Smart Investing Starts Here Start SIP with Thyrocare Technologies for Steady Growth!

Invest Now

Thyrocare Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 56.4
  • PEG Ratio
  • 1.1
  • Market Cap Cr
  • 7,208
  • P/B Ratio
  • 13.5
  • Average True Range
  • 19.35
  • EPS
  • 8.03
  • Dividend Yield
  • 2.1
  • MACD Signal
  • -6.13
  • RSI
  • 50.71
  • MFI
  • 73.19

Thyrocare Technologies Financials

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹452.90
-4.35 (-0.95%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹449.28
  • 50 Day
  • ₹448.65
  • 100 Day
  • ₹430.56
  • 200 Day
  • ₹392.10

Resistance and Support

451.73 Pivot Speed
  • R3 464.47
  • R2 459.83
  • R1 456.37
  • S1 448.27
  • S2 443.63
  • S3 440.17

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Ltd. is one of India’s leading diagnostic and preventive healthcare service providers, specializing in affordable and reliable pathology tests, including thyroid, diabetes, and wellness profiles, with a nationwide network of diagnostic labs and collection centers.

Thyrocare Technologies has an operating revenue of Rs. 762.64 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 21% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 21% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 33 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Thyrocare Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-14 Qtr Results, Int. Dividend & Bonus issue
2025-07-23 Quarterly Results
2025-04-23 Audited Results & Final Dividend
2025-01-23 Quarterly Results
2024-10-23 Quarterly Results
Date Purpose Remarks
2025-10-24 INTERIM Rs.7.00 per share(70%)Interim Dividend
2025-07-25 FINAL Rs.21.00 per share(210%)Final Dividend
2024-08-16 FINAL Rs.18.00 per share(180%)Final Dividend
2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend
View Thyrocare Technologies Dividend History Arrow
Date Purpose Remarks
2025-11-28 Bonus Rs.0.00 issue of equity shares in the ratio of 2:1 of Rs. 10/-.

Thyrocare Technologies F&O

Thyrocare Technologies Shareholding Pattern

60.93%
18.35%
0.73%
5.32%
0%
10.78%
3.89%

About Thyrocare Technologies

  • NSE Symbol
  • THYROCARE
  • BSE Symbol
  • 539871
  • Managing Director & CEO
  • Mr. Rahul Guha
  • ISIN
  • INE594H01019

Similar Stocks to Thyrocare Technologies

Thyrocare Technologies FAQs

Thyrocare Technologies share price is ₹452 As on 26 December, 2025 | 06:52

The Market Cap of Thyrocare Technologies is ₹7208.4 Cr As on 26 December, 2025 | 06:52

The P/E ratio of Thyrocare Technologies is 56.4 As on 26 December, 2025 | 06:52

The PB ratio of Thyrocare Technologies is 13.5 As on 26 December, 2025 | 06:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23